Approval · Notice of Compliance 803 · 2002
SPIRIVA: Notice of Compliance 803
Issued November 20, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 803
- Date
- November 20, 2002
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPIRIVA | 02246793 | Marketed |
Medicinal ingredients
- TIOTROPIUM BROMIDE MONOHYDRATE 18 MCG per CAP